Formycon AG (FYB)

Currency in EUR
19.36
-0.40(-2.02%)
Delayed Data·

FYB Earnings

Latest Release
Aug 12, 2026
EPS / Forecast
-- / -0.14
Revenue / Forecast
25.8M / 9M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/-0.080--/13.00M----Free Sign Up
2026/06--/-0.14025.80M/9.00M--+186.67%Free Sign Up
2026/03-0.190/0.02013.10M/18.00M-1,050%-27.22%Free Sign Up
2025/120.520/0.28030.25M/40.75M+85.71%-25.77%Free Sign Up
2025/09-0.350/-0.15010.50M/15.40M-133.33%-31.82%Free Sign Up
2025/06-3.07/-0.0809.00M/14.00M-3,737.5%-35.71%Free Sign Up
2025/03-0.850/-0.0405.30M/16.00M-2,025%-66.88%Free Sign Up
2024/12-6.53/0.03042.78M/18.00M-21,866.67%+137.67%Free Sign Up
2024/090.030/-0.03014.20M/15.00M+200%-5.33%Free Sign Up
2024/06-0.580/-0.29018.05M/26.90M-100%-32.9%Free Sign Up

All numbers in EUR

Formycon AG Earnings Call Summary for Q2/2026

  • H1 2026 revenue nearly tripled year-over-year; adjusted EBITDA improved to minus EUR 6.9M from minus EUR 19.2M in H1 2025.
  • FYB206 Keytruda biosimilar generated over 40% of H1 revenue; FYB202 Avastin biosimilar revenues more than tripled on royalties and milestones.
  • Management confirmed full-year 2026 guidance; expects H2 revenue growth driven by FYB202 U.S. distribution and European market expansion.
  • Cash fell to EUR 51.8M from EUR 68.8M at year-end 2025; company plans to add 2-3 pipeline molecules in H2 2026.
  • Shares down 0.31% to $19.10; stock trades 29% below 52-week high amid competitive biosimilar market and uneven revenue timing risks.
Last Updated: 2026-08-12, 09:54 a/m
Read Full Transcript

FAQ

When Is The Next Formycon Earnings Date?

Formycon will release its next earnings report on Nov 12, 2026.

What Is Formycon’s Revenue Forecasts For Upcoming Quarters?

Formycon’s revenue forecast is 13.00M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.